3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Sarcopenia
3
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Neoplasms
2
Wound Infection
1
Weight Loss
1
Surgical Wound Infection
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Psoriasis
1
Precancerous Conditions
1
Postoperative Complications
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Osteoarthritis
1
Olfaction Disorders
1
Obesity
1
Neuroma, Acoustic
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mandibular Neoplasms
1
Malnutrition
1
Fatigue
1
Dermatitis, Contact
1
Colorectal Neoplasms
1
Cancer Cachexia
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthralgia
1
Interventions
Vitamin D
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Psoriasis
×
Docosahexaenoic Acids
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts